$3.50
6.17% yesterday
Nasdaq, Dec 05, 10:14 pm CET
ISIN
US53216B1044
Symbol
LFMD

LifeMD Stock price

$3.50
-2.13 37.83% 1M
-8.58 71.03% 6M
-1.45 29.29% YTD
-1.97 36.01% 1Y
+0.89 34.10% 3Y
-4.42 55.81% 5Y
+2.93 508.70% 10Y
+3.20 1,066.67% 20Y
Nasdaq, Closing price Fri, Dec 05 2025
-0.23 6.17%
ISIN
US53216B1044
Symbol
LFMD

Key metrics

Basic
Market capitalization
$168.5m
Enterprise Value
$147.7m
Net debt
positive
Cash
$36.2m
Shares outstanding
45.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.7 | 0.7
EV/Sales
0.6 | 0.6
EV/FCF
22.0
P/B
negative
Financial Health
Equity Ratio
-7.6%
Return on Equity
400.8%
ROCE
-20.3%
ROIC
-
Debt/Equity
-8.7
Financials (TTM | estimate)
Revenue
$245.6m | $258.1m
EBITDA
$8.6m | $28.6m
EBIT
$-2.0m | $1.2m
Net Income
$-9.0m | $-6.3m
Free Cash Flow
$6.7m
Growth (TTM | estimate)
Revenue
37.7% | 21.5%
EBITDA
176.6% | 529.5%
EBIT
89.4% | 107.5%
Net Income
66.1% | 71.4%
Free Cash Flow
1.7%
Margin (TTM | estimate)
Gross
87.6%
EBITDA
3.5% | 11.1%
EBIT
-0.8%
Net
-3.7% | -2.4%
Free Cash Flow
2.7%
More
EPS
$-0.2
FCF per Share
$0.1
Short interest
10.9%
Employees
306
Rev per Employee
$690.0k
Show more

Is LifeMD a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,088 stocks worldwide.

LifeMD Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a LifeMD forecast:

12x Buy
86%
2x Hold
14%

Analyst Opinions

14 Analysts have issued a LifeMD forecast:

Buy
86%
Hold
14%

Financial data from LifeMD

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
246 246
38% 38%
100%
- Direct Costs 31 31
54% 54%
12%
215 215
36% 36%
88%
- Selling and Administrative Expenses 197 197
21% 21%
80%
- Research and Development Expense 10 10
31% 31%
4%
8.55 8.55
177% 177%
3%
- Depreciation and Amortization 11 11
31% 31%
4%
EBIT (Operating Income) EBIT -2.03 -2.03
89% 89%
-1%
Net Profit -9.03 -9.03
66% 66%
-4%

In millions USD.

Don't miss a Thing! We will send you all news about LifeMD directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LifeMD Stock News

Neutral
GlobeNewsWire
12 days ago
NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services and pharmacy solutions, today announced it has been recognized on both the 2025 Deloitte Technology Fast 500™ and the inaugural TIME's America's Growth Leaders of 2026 lists. These distinguished awards reflect LifeMD's continued revenue growth, financial stability, and em...
Neutral
Seeking Alpha
19 days ago
LifeMD, Inc. ( LFMD ) Q3 2025 Earnings Call November 17, 2025 4:30 PM EST Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Participants David Larsen - BTIG, LLC, Research Division Steven Valiquette - Mizuho Securities USA LLC, Research Division Anderson Schock - B. Riley Securities, Inc., Research Division Sarah James - Cantor Fitzge...
Neutral
GlobeNewsWire
19 days ago
Total revenue increased 13% year-over-year to $60.2 million, and adjusted EBITDA rose 20% to $5.1 million. Telehealth revenue grew 18% to $47.3 million, while telehealth adjusted EBITDA increased 30% to $2.9 million.
More LifeMD News

Company Profile

LifeMD, Inc. is a telehealth company, which engages in offering portfolio of direct-to-patient products and services. It combines virtual medical treatment with prescription medications and over-the-counter products. The firm's network of licensed physicians offers telemedicine services and direct-to-consumer pharmacy to consumers across the United States. The company's brands include Shapiro, Rex, and Nava. LifeMD was founded in 1987 and is headquartered in New York, NY.

Head office United States
CEO Justin Schreiber
Employees 306
Founded 1987
Website lifemd.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today